107 related articles for article (PubMed ID: 1564025)
1. Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity.
Sallee FR; Stiller RL; Perel JM
J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):244-51. PubMed ID: 1564025
[TBL] [Abstract][Full Text] [Related]
2. [Attention deficit hyperactivity disorder in children].
Bervoets L
J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
[No Abstract] [Full Text] [Related]
3. Stimulant medication and short attention span: a clinical approach.
Davy T; Rodgers CL
J Dev Behav Pediatr; 1989 Dec; 10(6):313-8. PubMed ID: 2513337
[TBL] [Abstract][Full Text] [Related]
4. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
[TBL] [Abstract][Full Text] [Related]
5. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
Rao JK; Julius JR; Breen TJ; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
[TBL] [Abstract][Full Text] [Related]
6. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.
Fitzpatrick PA; Klorman R; Brumaghim JT; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):226-34. PubMed ID: 1564023
[TBL] [Abstract][Full Text] [Related]
7. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder.
Sebrechts MM; Shaywitz SE; Shaywitz BA; Jatlow P; Anderson GM; Cohen DJ
Pediatrics; 1986 Feb; 77(2):222-8. PubMed ID: 3945535
[TBL] [Abstract][Full Text] [Related]
8. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
Miller LG; Kraft IA
Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
[TBL] [Abstract][Full Text] [Related]
9. Blood levels and tolerance to stimulants in ADDH children.
Swanson JM; Lerner M; Cantwell D
Clin Neuropharmacol; 1986; 9 Suppl 4():523-5. PubMed ID: 3567959
[No Abstract] [Full Text] [Related]
10. Sustained release methylphenidate: pharmacokinetic studies in ADDH males.
Birmaher B; Greenhill LL; Cooper TB; Fried J; Maminski B
J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):768-72. PubMed ID: 2793805
[TBL] [Abstract][Full Text] [Related]
11. The use of stimulant medication with children.
Phillips S
J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
[No Abstract] [Full Text] [Related]
12. Methylphenidate hydrochloride given with or before breakfast: I. Behavioral, cognitive, and electrophysiologic effects.
Swanson JM; Sandman CA; Deutsch C; Baren M
Pediatrics; 1983 Jul; 72(1):49-55. PubMed ID: 6866591
[TBL] [Abstract][Full Text] [Related]
13. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse.
Heiligenstein E; Anders J
J Am Coll Health; 1997 Mar; 45(5):225-9. PubMed ID: 9069682
[TBL] [Abstract][Full Text] [Related]
14. Attention deficit disorder in children: three clinical variants.
de Quirós GB; Kinsbourne M; Palmer RL; Rufo DT
J Dev Behav Pediatr; 1994 Oct; 15(5):311-9. PubMed ID: 7868698
[TBL] [Abstract][Full Text] [Related]
15. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
[No Abstract] [Full Text] [Related]
16. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
Quinn D; Bode T; Reiz JL; Donnelly GA; Darke AC
J Clin Pharmacol; 2007 Jun; 47(6):760-6. PubMed ID: 17395894
[TBL] [Abstract][Full Text] [Related]
17. [Drug-induced psychosis after intake of a modified--release formulation of methylphenidate].
Greiner C; Enss E; Haen E
Psychiatr Prax; 2009 Mar; 36(2):89-91. PubMed ID: 18504693
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
[TBL] [Abstract][Full Text] [Related]
19. Pemoline and lithium in a patient with attention deficit disorder.
Brown RP; Ingber PS; Tross S
J Clin Psychiatry; 1983 Apr; 44(4):146-8. PubMed ID: 6403515
[No Abstract] [Full Text] [Related]
20. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
Marcus SC; Wan GJ; Kemner JE; Olfson M
Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
